Dr. ID: 5810682
Lena Behrmann
Affiliations
1 - 5 out of 5Page size: 50
Publications
- 2021
The BET bromodomain inhibitor ZEN-3365 targets the Hedgehog signaling pathway in acute myeloid leukemia
Wellbrock, J., Behrmann, L., Muschhammer, J., Modemann, F., Khoury, K., Brauneck, F., Bokemeyer, C., Campeau, E. & Fiedler, W., 12.2021, In: ANN HEMATOL. 100, 12, p. 2933-2941 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2020
Downregulation of GLI3 Expression Mediates Chemotherapy Resistance in Acute Myeloid Leukemia
Freisleben, F., Behrmann, L., Thaden, V., Muschhammer, J., Bokemeyer, C., Fiedler, W. & Wellbrock, J., 18.07.2020, In: INT J MOL SCI. 21, 14Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
The bone marrow stromal niche: a therapeutic target of hematological myeloid malignancies
Behrmann, L., Wellbrock, J. & Fiedler, W., 05.2020, In: EXPERT OPIN THER TAR. 24, 5, p. 451-462 12 p.Research output: SCORING: Contribution to journal › SCORING: Review article › Research
- 2018
Acute Myeloid Leukemia and the Bone Marrow Niche-Take a Closer Look
Behrmann, L., Wellbrock, J. & Fiedler, W., 18.11.2018, In: FRONT ONCOL. 8, p. 444Research output: SCORING: Contribution to journal › SCORING: Review article › Research
Combined inhibition of receptor tyrosine and p21-activated kinases as a therapeutic strategy in childhood ALL
Siekmann, I-K., Dierck, K., Prall, S., Klokow, M., Strauss, J., Buhs, S., Wrzeszcz, A., Bockmayr, M., Beck, F., Trochimiuk, M., Gottschling, K., Martens, V., Khosh-Naucke, M., Gerull, H., Müller, J., Behrmann, L., Blohm, M., Zahedi, R. P., Jeremias, I., Sickmann, A., Nollau, P. & Horstmann, M. A., 09.10.2018, In: Blood Adv. 2, 19, p. 2554-2567 14 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
